Nanjing Long Term Debt vs Deferred Long Term Liab Analysis

688580 Stock

31.92 0.79 2.54%

Nanjing Vishee financial indicator trend analysis is infinitely more than just investigating Nanjing Vishee Medical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nanjing Vishee Medical is a good investment. Please check the relationship between Nanjing Vishee Long Term Debt and its Deferred Long Term Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Nanjing Vishee Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Long Term Debt vs Deferred Long Term Liab

Long Term Debt vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nanjing Vishee Medical Long Term Debt account and Deferred Long Term Liab. At this time, the significance of the direction appears to have pay attention.

The correlation between Nanjing Vishee's Long Term Debt and Deferred Long Term Liab is -0.78. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Nanjing Vishee Medical, assuming nothing else is changed. The correlation between historical values of Nanjing Vishee's Long Term Debt and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Nanjing Vishee Medical are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Long Term Debt i.e., Nanjing Vishee's Long Term Debt and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

-0.78

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Long Term Debt

Long-term debt is a debt that Nanjing Vishee Medical has held for over one year. Long-term debt appears on Nanjing Vishee Medical balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Nanjing Vishee Medical balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Most indicators from Nanjing Vishee's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nanjing Vishee Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Nanjing Vishee Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Tax Provision is expected to grow to about 16 M, whereas Selling General Administrative is forecasted to decline to about 96.7 M.

	2021	2022	2023	2024 (projected)
Gross Profit	321.6M	233.1M	331.7M	261.0M
Total Revenue	430.0M	321.6M	462.2M	355.7M

Gross Profit Total Revenue

Nanjing Vishee fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab	Deferred Long Term Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Net Working Capital	Intangible Assets	Common Stock
Total Assets		-0.32	0.79	1.0	-0.85	1.0	0.97	0.76	0.99	0.73	0.43	0.83	-0.87	0.87	0.9	-0.3	0.91	0.56	0.75	0.94	1.0	-0.09	0.99	0.99	0.66	0.98
Other Current Liab	-0.32		-0.17	-0.32	0.5	-0.28	-0.33	-0.68	-0.21	-0.75	0.2	-0.65	0.1	-0.59	-0.51	-0.72	-0.17	-0.64	-0.38	-0.16	-0.32	0.47	-0.22	-0.22	-0.84	-0.4
Total Current Liabilities	0.79	-0.17		0.77	-0.45	0.77	0.85	0.75	0.75	0.72	0.09	0.66	-0.95	0.73	0.77	-0.33	0.97	0.7	0.96	0.72	0.77	0.45	0.76	0.73	0.66	0.78
Total Stockholder Equity	1.0	-0.32	0.77		-0.85	1.0	0.97	0.75	0.99	0.71	0.45	0.83	-0.86	0.86	0.89	-0.31	0.9	0.54	0.73	0.94	1.0	-0.11	0.99	0.99	0.65	0.98
Other Liab	-0.85	0.5	-0.45	-0.85		-0.84	-0.75	-0.61	-0.85	-0.67	-0.35	-0.77	0.56	-0.82	-0.78	0.11	-0.61	-0.48	-0.44	-0.86	-0.85	0.56	-0.85	-0.86	-0.64	-0.85
Net Tangible Assets	1.0	-0.28	0.77	1.0	-0.84		0.97	0.73	0.99	0.69	0.46	0.81	-0.85	0.84	0.89	-0.32	0.89	0.51	0.72	0.95	1.0	-0.1	0.99	0.99	0.61	0.98
Retained Earnings	0.97	-0.33	0.85	0.97	-0.75	0.97		0.78	0.94	0.78	0.46	0.88	-0.91	0.89	0.92	-0.28	0.93	0.66	0.82	0.87	0.97	0.06	0.94	0.94	0.69	0.96
Accounts Payable	0.76	-0.68	0.75	0.75	-0.61	0.73	0.78		0.67	0.82	-0.02	0.78	-0.68	0.74	0.78	0.27	0.75	0.67	0.86	0.64	0.75	0.0	0.68	0.66	0.88	0.77
Cash	0.99	-0.21	0.75	0.99	-0.85	0.99	0.94	0.67		0.64	0.48	0.77	-0.86	0.82	0.83	-0.42	0.88	0.45	0.67	0.95	0.99	-0.1	1.0	1.0	0.56	0.94
Non Current Assets Total	0.73	-0.75	0.72	0.71	-0.67	0.69	0.78	0.82	0.64		0.06	0.91	-0.69	0.94	0.85	0.15	0.72	0.95	0.8	0.56	0.72	-0.07	0.65	0.64	0.97	0.77
Non Currrent Assets Other	0.43	0.2	0.09	0.45	-0.35	0.46	0.46	-0.02	0.48	0.06		0.43	-0.34	0.32	0.22	-0.53	0.24	-0.04	-0.05	0.34	0.45	-0.05	0.48	0.49	-0.11	0.35
Other Assets	0.83	-0.65	0.66	0.83	-0.77	0.81	0.88	0.78	0.77	0.91	0.43		-0.73	0.96	0.84	0.0	0.72	0.79	0.69	0.65	0.83	-0.14	0.78	0.78	0.85	0.83
Long Term Debt	-0.87	0.1	-0.95	-0.86	0.56	-0.85	-0.91	-0.68	-0.86	-0.69	-0.34	-0.73		-0.78	-0.75	0.5	-0.98	-0.62	-0.87	-0.78	-0.86	-0.37	-0.87	-0.85	-0.6	-0.81
Net Receivables	0.87	-0.59	0.73	0.86	-0.82	0.84	0.89	0.74	0.82	0.94	0.32	0.96	-0.78		0.91	-0.09	0.8	0.86	0.74	0.74	0.86	-0.15	0.82	0.82	0.86	0.89
Common Stock Shares Outstanding	0.9	-0.51	0.77	0.89	-0.78	0.89	0.92	0.78	0.83	0.85	0.22	0.84	-0.75	0.91		-0.03	0.83	0.77	0.8	0.83	0.89	-0.14	0.84	0.83	0.78	0.96
Non Current Liabilities Total	-0.3	-0.72	-0.33	-0.31	0.11	-0.32	-0.28	0.27	-0.42	0.15	-0.53	0.0	0.5	-0.09	-0.03		-0.4	0.13	-0.06	-0.38	-0.3	-0.38	-0.41	-0.41	0.33	-0.19
Inventory	0.91	-0.17	0.97	0.9	-0.61	0.89	0.93	0.75	0.88	0.72	0.24	0.72	-0.98	0.8	0.83	-0.4		0.64	0.91	0.85	0.89	0.29	0.89	0.87	0.64	0.88
Other Current Assets	0.56	-0.64	0.7	0.54	-0.48	0.51	0.66	0.67	0.45	0.95	-0.04	0.79	-0.62	0.86	0.77	0.13	0.64		0.78	0.4	0.54	0.09	0.47	0.45	0.88	0.63
Total Liab	0.75	-0.38	0.96	0.73	-0.44	0.72	0.82	0.86	0.67	0.8	-0.05	0.69	-0.87	0.74	0.8	-0.06	0.91	0.78		0.65	0.73	0.37	0.68	0.66	0.79	0.77
Deferred Long Term Liab	0.94	-0.16	0.72	0.94	-0.86	0.95	0.87	0.64	0.95	0.56	0.34	0.65	-0.78	0.74	0.83	-0.38	0.85	0.4	0.65		0.94	-0.17	0.95	0.95	0.5	0.93
Net Invested Capital	1.0	-0.32	0.77	1.0	-0.85	1.0	0.97	0.75	0.99	0.72	0.45	0.83	-0.86	0.86	0.89	-0.3	0.89	0.54	0.73	0.94		-0.11	0.99	0.99	0.65	0.98
Short Long Term Debt	-0.09	0.47	0.45	-0.11	0.56	-0.1	0.06	0.0	-0.1	-0.07	-0.05	-0.14	-0.37	-0.15	-0.14	-0.38	0.29	0.09	0.37	-0.17	-0.11		-0.09	-0.12	-0.13	-0.15
Total Current Assets	0.99	-0.22	0.76	0.99	-0.85	0.99	0.94	0.68	1.0	0.65	0.48	0.78	-0.87	0.82	0.84	-0.41	0.89	0.47	0.68	0.95	0.99	-0.09		1.0	0.57	0.95
Net Working Capital	0.99	-0.22	0.73	0.99	-0.86	0.99	0.94	0.66	1.0	0.64	0.49	0.78	-0.85	0.82	0.83	-0.41	0.87	0.45	0.66	0.95	0.99	-0.12	1.0		0.56	0.94
Intangible Assets	0.66	-0.84	0.66	0.65	-0.64	0.61	0.69	0.88	0.56	0.97	-0.11	0.85	-0.6	0.86	0.78	0.33	0.64	0.88	0.79	0.5	0.65	-0.13	0.57	0.56		0.7
Common Stock	0.98	-0.4	0.78	0.98	-0.85	0.98	0.96	0.77	0.94	0.77	0.35	0.83	-0.81	0.89	0.96	-0.19	0.88	0.63	0.77	0.93	0.98	-0.15	0.95	0.94	0.7

Click cells to compare fundamentals

Nanjing Vishee Account Relationship Matchups

Nanjing Vishee fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	404.2M	1.5B	1.6B	1.7B	1.8B	1.2B
Other Current Liab	99.1M	94.0M	75.3M	2.1M	1.3M	1.2M
Total Current Liabilities	141.6M	128.7M	103.9M	129.2M	151.7M	129.0M
Total Stockholder Equity	249.2M	1.4B	1.5B	1.5B	1.6B	1.0B
Net Tangible Assets	230.0M	1.4B	1.5B	1.4B	1.6B	885.8M
Retained Earnings	178.7M	272.5M	378.5M	349.1M	438.4M	284.0M
Accounts Payable	10.5M	9.9M	9.3M	19.7M	18.0M	13.1M
Cash	244.4M	1.4B	1.4B	1.2B	1.2B	892.2M
Non Current Assets Total	121.9M	121.6M	204.4M	365.0M	551.2M	578.8M
Non Currrent Assets Other	1.3M	191.8K	71.9M	6.1M	1.4M	1.3M
Other Assets	640.7K	1.3M	3.4M	85.4M	98.2M	103.1M
Net Receivables	1.6M	12.9M	24.3M	21.1M	36.6M	38.5M
Non Current Liabilities Total	7.7M	776.2K	1.8M	26.4M	27.6M	16.3M
Inventory	31.5M	37.1M	30.4M	34.8M	39.9M	32.7M
Other Current Assets	4.8M	1.1M	3.0M	4.3M	12.6M	13.2M
Total Liab	149.4M	129.5M	105.7M	155.7M	179.3M	145.3M
Deferred Long Term Liab	33.9K	294.8K	1.1M	768.8K	884.1K	528.3K
Net Invested Capital	263.2M	1.4B	1.5B	1.5B	1.6B	1.1B
Short Long Term Debt	10M	1.1M	1.2M	1.2M	1.1M	1.0M
Total Current Assets	282.3M	1.4B	1.4B	1.3B	1.3B	950.4M
Net Working Capital	140.7M	1.3B	1.3B	1.2B	1.1B	821.4M
Intangible Assets	19.2M	20.0M	18.8M	106.5M	120.6M	126.6M
Property Plant Equipment	102.5M	101.3M	98.3M	100.3M	115.3M	103.9M

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

Other Information on Investing in Nanjing Stock

Balance Sheet is a snapshot of the financial position of Nanjing Vishee Medical at a specified time, usually calculated after every quarter, six months, or one year. Nanjing Vishee Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Nanjing Vishee and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Nanjing currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Nanjing Long Term Debt vs Deferred Long Term Liab Analysis

Long Term Debt vs Deferred Long Term Liab

Long Term Debt vs Deferred Long Term Liab Correlation Analysis

Correlation Coefficient

Long Term Debt

Deferred Long Term Liab

Nanjing Vishee fundamental ratios Correlations

Nanjing Vishee Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Nanjing Vishee fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Nanjing Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Net Tangible Assets	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Net Tangible Assets	+ 1.0	Total Stockholder Equity
Net Invested Capital	+ 1.0	Total Stockholder Equity
Net Invested Capital	+ 1.0	Net Tangible Assets

Inventory	- 0.98	Long Term Debt
Long Term Debt	- 0.95	Total Current Liabilities
Long Term Debt	- 0.91	Retained Earnings
Total Current Assets	- 0.87	Long Term Debt
Total Liab	- 0.87	Long Term Debt
Long Term Debt	- 0.87	Total Assets